FDA Import Refusal SCS-1742749-1/40002/1 — Chongqing Sintaho Pharmaceuticals Co., Ltd.
The FDA refused shipment SCS-1742749-1/40002/1 from Chongqing Sintaho Pharmaceuticals Co., Ltd. (China) on Aug 6, 2026. The refused product falls under Drugs and Biologics — ORFORGLIPRON (ANTI-DIABETIC). Cited charge: 27 This firm has 3 other import refusals on record.
Refusal Details
- Date
- Aug 6, 2026
- Country
- China
- Product Category
- Drugs and Biologics
- Product Code
- 61PIY77 ORFORGLIPRON (ANTI-DIABETIC)
- Charges
- 27